Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
The price of Phreesia Inc (NYSE: PHR) closed at $28.07 in the last session, up 2.22% from day before closing price of $27.46. In other words, the price has increased by $2.22 from its previous closing price. On the day, 0.56 million shares were traded. PHR stock price reached its highest trading level at $28.26 during the session, while it also had its lowest trading level at $27.62.
Ratios:
We take a closer look at PHR’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 19.59 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 70.14. For the most recent quarter (mrq), Quick Ratio is recorded 1.78 and its Current Ratio is at 1.78. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, RBC Capital Mkts on January 08, 2025, Upgraded its rating to Outperform and sets its target price to $32 from $24 previously.
On February 26, 2024, Truist started tracking the stock assigning a Buy rating and target price of $35.
DA Davidson Upgraded its Neutral to Buy on January 17, 2024, whereas the target price for the stock was revised from $30 to $32.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 19 ’25 when Linetsky David sold 88 shares for $27.88 per share. The transaction valued at 2,454 led to the insider holds 8,724 shares of the business.
Linetsky David sold 39 shares of PHR for $1,051 on Mar 18 ’25. The SVP, Life Sciences now owns 8,812 shares after completing the transaction at $26.95 per share. On Mar 17 ’25, another insider, Hoffman Allison C, who serves as the General Counsel & Secretary of the company, sold 3,496 shares for $25.32 each. As a result, the insider received 88,519 and left with 139,134 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PHR now has a Market Capitalization of 1649741312 and an Enterprise Value of 1222525568. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.93 while its Price-to-Book (P/B) ratio in mrq is 6.23. Its current Enterprise Value per Revenue stands at 2.912 whereas that against EBITDA is -34.502.
Stock Price History:
The Beta on a monthly basis for PHR is 0.80, which has changed by 0.18438816 over the last 52 weeks, in comparison to a change of 0.10838497 over the same period for the S&P500. Over the past 52 weeks, PHR has reached a high of $30.53, while it has fallen to a 52-week low of $17.07. The 50-Day Moving Average of the stock is 2.91%, while the 200-Day Moving Average is calculated to be 19.26%.
Shares Statistics:
According to the various share statistics, PHR traded on average about 433.78K shares per day over the past 3-months and 758650 shares per day over the past 10 days. A total of 58.73M shares are outstanding, with a floating share count of 53.78M. Insiders hold about 8.49% of the company’s shares, while institutions hold 92.97% stake in the company. Shares short for PHR as of 1740700800 were 2063064 with a Short Ratio of 4.76, compared to 1738281600 on 2503873. Therefore, it implies a Short% of Shares Outstanding of 2063064 and a Short% of Float of 4.31.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
